A4
Showing 1 - 25 of >10,000
Ovarian Cancer Trial (Autologous genetically modified ADP-A2M4CD8 cells, Autologous genetically modified ADP-A2M4CD8 cells in
Not yet recruiting
- Ovarian Cancer
- Autologous genetically modified ADP-A2M4CD8 cells
- Autologous genetically modified ADP-A2M4CD8 cells in combination with Nivolumab
- (no location specified)
Jan 31, 2023
Epidemic Meningitis Trial (MCV4, MSPV4)
Not yet recruiting
- Epidemic Meningitis
- MCV4
- MSPV4
- (no location specified)
Aug 21, 2023
Clinical Phenotypic Characteristics of SC26A4
Recruiting
- Hearing Loss
- Pendred Syndrome
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Jul 24, 2023
CYP3A4*22 Trial (Palbociclib 125Mg Tab, Ribociclib 200Mg Oral Tablet, Abemaciclib 150 MG Oral Tablet)
Not yet recruiting
- CYP3A4*22
- Palbociclib 125Mg Tab
- +2 more
- (no location specified)
Jan 10, 2023
Healthy Volunteers Trial (Brensocatib, Clarithromycin)
Not yet recruiting
- Healthy Volunteers
- (no location specified)
Jul 19, 2023
Periodontitis, Diagnose Disease Trial in Istanbul (Saliva and serum sampling)
Completed
- Periodontitis
- Diagnose Disease
- Saliva and serum sampling
-
Istanbul, Fatih, TurkeyIstanbul Medipol University, School of Dentistry
Jun 17, 2022
Drug Interactions Trial in Austin (CYP450 Cocktail and Transporter Substrates with Pacritinib, Part 2 -Group A Bosentan 125 mg
Recruiting
- Drug Interactions
- CYP450 Cocktail and Transporter Substrates with Pacritinib
- +2 more
-
Austin, TexasPPD - Austin Research Unit
Jan 13, 2023
Urinary Bladder Cancer, Melanoma, Head Neck Cancer Trial in Canada, United States (Autologous genetically modified MAGE-A4?¹º³²T
Active, not recruiting
- Urinary Bladder Cancer
- +9 more
- Autologous genetically modified MAGE-A4ᶜ¹º³²T cells
- Autologous genetically modified MAGE-A4c1032T cells combined with low dose radiation
-
Miami, Florida
- +10 more
Aug 9, 2022
Athletic Injuries Trial in Valencia (Exercise training)
Recruiting
- Athletic Injuries
- Exercise training
-
Valencia, SpainFernando Domínguez Navarro
Apr 21, 2023
Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified
Recruiting
- Endometrial Cancer
- +8 more
- Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
-
Orlando, Florida
- +21 more
Feb 2, 2023
Healthy Volunteers Trial in Tempe (TAK-279, Erythromycin, Phenytoin)
Not yet recruiting
- Healthy Volunteers
- TAK-279
- +3 more
-
Tempe, ArizonaCelerion - Tempe, AZ Site
Aug 9, 2023
Alport Syndrome Trial in Shanghai (Ramipril)
Not yet recruiting
- Alport Syndrome
-
Shanghai, ChinaXinhua Hospital, Shanghai Jiao Tong University School of Medicin
Nov 23, 2021
Translational-Omics in Aortic Stenosis (TOmAS) Biobank
Recruiting
- Cardiovascular Diseases
- Aortic Valve Stenosis
- Genetics
-
Montréal, Quebec, Canada
- +1 more
Jun 29, 2023
Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neuroblastoma Trial in United States (Afamitresgene
Not yet recruiting
- Synovial Sarcoma
- +3 more
- Afamitresgene autoleucel
-
Palo Alto, California
- +3 more
Dec 6, 2022
Melasma Trial in Abbottabad (Group A 4 % Hydroquinone Cream Topically and Oral Tranexamic Acid, Group B Azelaic Acid 20 % Cream
Completed
- Melasma
- Group A 4 % Hydroquinone Cream Topically and Oral Tranexamic Acid
- Group B Azelaic Acid 20 % Cream for 6 months
-
Abbottabad, KPK, PakistanZahra Nigar
May 31, 2023
Parkinson Disease Trial in Madison (Tavapadon, Carbamazepine)
Active, not recruiting
- Parkinson Disease
-
Madison, WisconsinMadison, Wisconsin
Jan 13, 2023
Birch Pollen Allergy Trial in Mississauga (DM-101PX, Placebo to Match DM-101PX)
Recruiting
- Birch Pollen Allergy
- DM-101PX
- Placebo to Match DM-101PX
-
Mississauga, Ontario, CanadaCliantha Research
Sep 18, 2023
Rabies Vaccine Adverse Reaction Trial in Changsha (Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma - 5-dose
Completed
- Rabies Vaccine Adverse Reaction
- Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma - 5-dose program
- +3 more
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Oct 9, 2023
Cholesterol and CYP3A4/5 Metabolism Across Pregnancy and
Enrolling by invitation
- Pregnancy Related
-
Chicago, IllinoisNorthwestern University Asher Center for the Study and Treatment
Aug 15, 2022
Drug Interaction Trial in Uppsala (Drug Drug Interaction)
Recruiting
- Drug Interaction
- Drug Drug Interaction
-
Uppsala, SwedenCTC Clinical Trial Consultants AB
Apr 13, 2023
Cervical Intraepithelial Neoplasia Grade 2, DNA Methylation Trial in Maribor (Testing DNA methylation test for predicting
Recruiting
- Cervical Intraepithelial Neoplasia Grade 2
- DNA Methylation
- Testing DNA methylation test for predicting prognosis of untreated CIN 2
-
Maribor, SloveniaUniversity Medical Centre Maribor
Nov 14, 2022
Assessing Movement Disorder Patients P1A4
Recruiting
- Movement Disorders
-
Minneapolis, MinnesotaUniversity Of Minnesota
Jan 2, 2023
Infant Development Trial (Infant Formula)
Not yet recruiting
- Infant Development
- Infant Formula
- (no location specified)
Jul 17, 2023
Affect, Wellness, Psychological, Depressive Symptoms Trial in Montreal (A 4-week walking intervention)
Active, not recruiting
- Affect
- +6 more
- A 4-week walking intervention
-
Montreal, Quebec, CanadaDouglas Mental Health University Institute
May 25, 2023